• L-Alanyl-L-Glutamine (B8228): Practical Lab Use and Protocol

  2026-04-29

  L-Alanyl-L-Glutamine (SKU B8228) addresses the instability of free L-glutamine in aqueous solutions, providing a reliable dipeptide alternative for protocols requiring sustained support of intestinal barrier function, antioxidant activity, or cell viability. It is best suited for workflows where solubility, stability, and purity are paramount; it is not recommended for applications needing organic solvent compatibility or extended aqueous storage.

• Tin Mesoporphyrin IX: Precision Heme Oxygenase Assay Solutio

  2026-04-28

  Tin Mesoporphyrin IX (chloride) empowers metabolic, virological, and translational researchers to achieve unparalleled precision in modulating heme oxygenase activity. With robust experimental workflows and troubleshooting insights, this guide details how APExBIO’s high-affinity inhibitor streamlines both discovery and advanced applications.

• UHRF1, DNA Methylation, and Super-Enhancer Dynamics in Senil

  2026-04-28

  This study reveals how UHRF1-mediated DNA 5-mC modifications orchestrate super-enhancer redistribution in mesenchymal stem cells, impairing osteogenesis in senile osteoporosis through TGM2-regulated autophagic flux. The findings provide a mechanistic link between epigenetic regulation, enhancer landscape, and bone loss, highlighting new avenues for targeted epigenetics research and potential therapeutic intervention.

• Coumestrol in Rheumatoid Arthritis: Mechanisms and Protocols

  2026-04-27

  Explore how Coumestrol, a potent phytoestrogen estrogen receptor antagonist, drives ferroptosis and anti-inflammatory effects in rheumatoid arthritis models. This article offers deeper mechanistic insights and actionable guidance for advanced SERM studies.

• USP36-Snail1 Axis Drives Ribosome Biogenesis in Cancer Stres

  2026-04-27

  This study uncovers how USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival during ribotoxic stress. The findings reveal a mechanism of solid tumor resistance to ribosome-targeting therapy and provide a rationale for targeting the JNK-USP36-Snail1 axis in cancer research.

• GSK3 Inhibition as a Host-Directed Strategy Against Tubercul

  2026-04-26

  This article reviews recent findings demonstrating that inhibition of glycogen synthase kinase 3 (GSK3) can control Mycobacterium tuberculosis (Mtb) growth within macrophages. The study introduces host-directed therapy as a viable adjunct to traditional antibiotic approaches, with implications for multi-drug resistant tuberculosis treatment.

• Applied Workflows with the HyperScribe SP6 High Yield RNA Sy

  2026-04-25

  Accelerate capped, labeled, and high-yield RNA synthesis with the HyperScribe SP6 High Yield RNA Synthesis Kit. This article bridges advanced use-cases, experimental enhancements, and troubleshooting, empowering RNA vaccine, probe, and interference research with evidence-based protocols.

• Gap19: Selective Connexin 43 Hemichannel Blocker for Neuropr

  2026-04-24

  Gap19 enables precise, selective inhibition of Cx43 hemichannels without affecting gap junction channels, making it a gold-standard tool for dissecting neuroglial and immune signaling. This article translates key findings from recent research into actionable protocols and troubleshooting guidance for advanced neuroprotection and inflammation assays.

• Birinapant (TL32711): Precision Apoptosis Induction Workflow

  2026-04-24

  Birinapant (TL32711) empowers cancer researchers to unravel apoptosis resistance with data-driven workflows and robust troubleshooting. Leveraging recent mechanistic breakthroughs, this guide delivers actionable experimental enhancements and protocol parameters for optimized IAP antagonism in translational oncology.

• Wnt and BMP Pathways in Hemichordate Neuroectoderm Patternin

  2026-04-23

  This study elucidates how Wnt and BMP signaling gradients coordinate the anterior neuroectoderm (ANE) development in the indirect-developing hemichordate Ptychodera flava. The findings not only clarify evolutionary conservation of these pathways among deuterostomes but also offer mechanistic insight for researchers leveraging PORCN inhibitors to dissect Wnt pathway function.

• Moxifloxacin: Fluoroquinolone Antibiotic in Toxicity Researc

  2026-04-23

  Moxifloxacin stands apart as a research-grade fluoroquinolone antibiotic, uniquely suited for probing DNA gyrase inhibition, cytotoxicity, and metabolic responses in both cell and animal models. This article dives into experimental workflows, troubleshooting, and advanced use-cases—anchored by mechanistic clarity and data-driven insights.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-04-22

  The reference study reveals that naturally occurring angiotensin peptides, including short C- and N-terminal fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, with implications for COVID-19 pathogenesis. These findings introduce a mechanistic bridge between the renin-angiotensin system and viral entry processes, informing both cardiovascular and infectious disease research.

• Butylhydroxyanisole (BHA): Advanced Insights for ROS Pathway

  2026-04-22

  Explore the advanced scientific mechanisms and assay design strategies enabled by Butylhydroxyanisole (BHA) in oxidative stress and apoptosis research. This article uniquely connects BHA’s molecular action to practical assay optimization, offering expertise beyond standard workflow guides.

• Ceruletide in Pancreatic Fibrosis Models: Scientific Rationa

  2026-04-21

  Explore the advanced scientific rationale for using Ceruletide (caerulein) in pancreatic fibrosis research. This in-depth guide details mechanistic insights, assay design, and integration of the latest findings for optimized gastrointestinal physiology studies.

• USP7-PKM2 Axis Modulates Macrophage Polarization in Pancreat

  2026-04-21

  This study uncovers the regulatory role of ubiquitin-specific protease 7 (USP7) in macrophage polarization during severe acute pancreatitis (SAP) via pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. The findings elucidate the mechanistic link between immunometabolism and inflammation in SAP, suggesting PKM2 inhibition as a targeted approach for modulating disease progression.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page